Company
ChinaShandong Lixin Pharmaceutical Co., Ltd., China – FDA Inspections
Inspection records and compliance data for Shandong Lixin Pharmaceutical Co., Ltd.. 1 FDA inspection on record, last inspected May 19, 2023.
Company Profile
This profile covers Shandong Lixin Pharmaceutical Co., Ltd. based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected May 19, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 19, 2023 | Not classified | Human Drugs | 1209019 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Suzhou Lixin Pharmaceutical Co. Ltd.
Esteve Huayi Pharmaceutical Co., Ltd.
Qingdao Jiulong Biopharmaceutical Co. Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Tien (Tianjin) Pharmaceutical Co., Ltd.
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
NANJING HAIRUN PHARMACEUTICAL CO., LTD.
BrightGene Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd. (Laoling Site)
Corden Pharma Switzerland LLC
Company Information
Name
Shandong Lixin Pharmaceutical Co., Ltd.
FEI Number
3017297099
Address
China
Country
China
ID: 8a4f310a-938e-4a84-bbed-5d99db6ce845